Cosciens Biopharma (LTS:0UGB) FCF Margin % : -422.81% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cosciens Biopharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cosciens Biopharma's Free Cash Flow for the three months ended in Sep. 2024 was C$-10.71 Mil. Cosciens Biopharma's Revenue for the three months ended in Sep. 2024 was C$2.53 Mil. Therefore, Cosciens Biopharma's FCF Margin % for the quarter that ended in Sep. 2024 was -422.81%.

As of today, Cosciens Biopharma's current FCF Yield % is -150.39%.

The historical rank and industry rank for Cosciens Biopharma's FCF Margin % or its related term are showing as below:

LTS:0UGB' s FCF Margin % Range Over the Past 10 Years
Min: -187.36 Med: -1.4 Max: 33.17
Current: -187.36

During the past 13 years, the highest FCF Margin % of Cosciens Biopharma was 33.17%. The lowest was -187.36%. And the median was -1.40%.

LTS:0UGB's FCF Margin % is ranked worse than
55.59% of 1011 companies
in the Biotechnology industry
Industry Median: -127.22 vs LTS:0UGB: -187.36

Cosciens Biopharma FCF Margin % Historical Data

The historical data trend for Cosciens Biopharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma FCF Margin % Chart

Cosciens Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

4.22

25.36

16.29

33.17

-47.78

Cosciens Biopharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															4.81	-137.92	-144.19	-66.16	-422.81

Competitive Comparison of Cosciens Biopharma's FCF Margin %

For the Biotechnology subindustry, Cosciens Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosciens Biopharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Cosciens Biopharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cosciens Biopharma's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.655	/	9.743
	=	-47.78 %

Cosciens Biopharma's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-10.714	/	2.534
	=	-422.81 %

Cosciens Biopharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosciens Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (LTS:0UGB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CSCI:USA ET8:Germany CSCI:Canada

Address

c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.

Cosciens Biopharma Headlines

No Headlines